LONDON (ShareCast) - (Sharecast News) - Life sciences company OptiBiotix Health has entered into an exclusive agreement with DKSH International to distribute its 'SlimBiome' proprietary weight management technology in Italy and Spain, it announced on Wednesday.
The AIM-traded firm said market exclusivity would linked to sales orders, in order to maximise the financial return for both parties and provide some surety of income for OptiBiotix over the next three years.

It described DKSH as a leading market expansion services provider, which helps companies and brands to grow in the consumer goods, healthcare, performance materials and technology sectors.

DKSH's portfolio of services included sourcing, market insights, marketing and sales, distribution and logistics as well as after-sales services.

Publicly listed on the SIX Swiss Exchange, DKSH operates in 35 markets with 33,000 specialists, generating net sales of CHF 11.3bn in 2018.

The agreement continued OptiBiotix's strategy of expanding SlimBiome and SlimBiome-related products, such as its own 'GoFigure' brand for weight management, into key European markets.

It described SlimBiome as a patented formulation developed by experts in nutrition using ingredients shown to reduce weight in human studies.

Independent human studies at a number of universities had shown SlimBiome reduced hunger and cravings for sweet, fatty and savoury foods, leading to an average two-to-three pound per week weight loss.

"We are pleased to announce the signing of this agreement with such a strong global partner focusing on the Italian and Spanish markets," said OptiBiotix sales and marketing director Christina Wood.

"With its strong Swiss heritage and long business tradition since 1865, DKSH is a highly successful global corporation with a strong positioning in both consumer goods, including foods and beverages, as well as healthcare and technology - key areas for our weight management products.

"We are delighted that DKSH will be bringing their marketing and sales expertise to promote the sale of SlimBiome."

Wood said that, with its industry awards, clinical studies demonstrating safety and efficacy, medical device registration and CE mark, the company believed SlimBiome was "highly differentiated" from other weight management products.

"We hope combining these attributes with DKSH's sales, marketing and distribution expertise will generate substantial revenues in the months and years ahead."

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE